Latest news with #Adtalem
Yahoo
23-05-2025
- Business
- Yahoo
Here's How Much a $1000 Investment in Adtalem Global Education Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. Another thing that can drive investing is the fear of missing out, or FOMO. This particularly applies to tech giants and popular consumer-facing stocks. What if you'd invested in Adtalem Global Education (ATGE) ten years ago? It may not have been easy to hold on to ATGE for all that time, but if you did, how much would your investment be worth today? With that in mind, let's take a look at Adtalem Global Education's main business drivers. Adtalem Global Education Inc. is a leading healthcare education provider and workforce solutions innovator. The institutions of the company offer a wide array of programs across medical and healthcare services. Since first-quarter fiscal 2022, Adtalem has operated in three reportable segments:Chamberlain includes the operations of Chamberlain University, founded in 1889 as Deaconess College of Nursing and acquired by Adtalem in 2005. The segment offers degree and non-degree programs in the nursing and health professions postsecondary education includes the operations of Walden University, which Adtalem acquired on August 12, 2021. The segment offers more than 100 online certificate, bachelor's, master's and doctoral and Veterinary includes the operations of the AUC, RUSM, and RUSVM, which are collectively referred to as the 'medical and veterinary schools'. This segment offers degree and non-degree programs in the medical and veterinary postsecondary education Office and Other include activities that are not related to any reportable segment and are required to reconcile segmental the second quarter of fiscal 2022, Adtalem eliminated its Financial Services segment when ACAMS, Becker, OCL, and EduPristine were classified as discontinued operations and assets held for sale. On Mar 10, 2022, the company completed the sale of ACAMS, Becker and OCL. On Jun 17, 2022, it completed the divesture of EduPristine. Anyone can invest, but building a successful investment portfolio requires research, patience, and a little bit of risk. So, if you had invested in Adtalem Global Education ten years ago, you're likely feeling pretty good about your investment today. According to our calculations, a $1000 investment made in May 2015 would be worth $4,013.12, or a 301.31% gain, as of May 23, 2025. Investors should keep in mind that this return excludes dividends but includes price appreciation. In comparison, the S&P 500 gained 174.78% and the price of gold went up 162% over the same time frame. Looking ahead, analysts are expecting more upside for ATGE. Adtalem posted impressive third-quarter fiscal 2025 results, wherein adjusted earnings and revenues topped the Zacks Consensus Estimates by 17.8% and 4.9%, respectively. Both metrics increased year over year by 28% and 12.9%. This upside was backed by strong enrollment growth and higher tuition rates. Also, its focus on strategic initiatives and the efficient execution of the Growth with Purpose strategy is boding well. Total student enrollment rose 9.8% year over year to 94,223 students in the quarter. Owing to the trend of results and favorable aspects, the company raised its fiscal 2025 guidance across revenues and adjusted earnings. Shares of Adtalem have outperformed the industry in the year-to-date period. However, margin pressure in the Medical and Veterinary segment and increased expenses are concerning. Over the past four weeks, shares have rallied 22.99%, and there have been 1 higher earnings estimate revisions in the past two months for fiscal 2025 compared to none lower. The consensus estimate has moved up as well. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Adtalem Global Education Inc. (ATGE) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Washington Post
08-05-2025
- Business
- Washington Post
Adtalem: Fiscal Q3 Earnings Snapshot
CHICAGO — CHICAGO — Adtalem Global Education Inc. (ATGE) on Thursday reported fiscal third-quarter earnings of $60.8 million. The Chicago-based company said it had profit of $1.59 per share. Earnings, adjusted for one-time gains and costs, came to $1.92 per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.63 per share.
Time Magazine
08-05-2025
- Health
- Time Magazine
Steve Beard
Steve Beard knows that diverse health care is better health care. The belief drives his efforts as CEO of Adtalem Global Education, a corporation that operates institutions for higher learning including Chamberlain University, Walden University, and Ross University School of Medicine. 'Science shows the benefits of a diverse health care workforce, and no one makes a larger contribution to that goal than Adtalem's institutions,' Beard says. Under his leadership, Adtalem has made large strides in addressing shortages of health care workers while increasing racial representation. With more than 90,000 students currently enrolled at its schools, Adtalem has become one of the leading suppliers of doctors, nurses, veterinarians, and social workers to the U.S. workforce. Adtalem's medical schools are major producers of Black physicians in the U.S.—and over the past year, 95% of its medical school graduates have successfully secured hospital residencies, helping to shore up critical areas like primary care and underserved communities. Beard's institutions are at the forefront of technology. In 2024, Adtalem forged a new partnership with Hippocratic AI, developing curricula to train nursing students—and soon physicians—to use AI tools to monitor patients and improve follow-ups after treatment. 'Some of these innovations will relieve administrative burdens in ways that create better quality of life, on the hospital floor and at the bedside,' Beard path from first-generation college student to changemaker is a personal success story—and through Adtalem, it's become a model for building the next generation of health care professionals.
Yahoo
22-04-2025
- Business
- Yahoo
Adtalem (ATGE) Surges 7.8%: Is This an Indication of Further Gains?
Adtalem Global Education ATGE shares ended the last trading session 7.8% higher at $106.48. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5.5% gain over the past four weeks. Following President Trump's announcement to suspend U.S. tariffs on most countries for 90 days, Adtalem shares soared, reflecting renewed investor optimism. This for-profit education company is expected to post quarterly earnings of $1.63 per share in its upcoming report, which represents a year-over-year change of +8.7%. Revenues are expected to be $443.49 million, up 7.5% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For Adtalem, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ATGE going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Adtalem is part of the Zacks Schools industry. Laureate Education (LAUR), another stock in the same industry, closed the last trading session 6.7% higher at $19.56. LAUR has returned -3.9% in the past month. Laureate Education's consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.08. Compared to the company's year-ago EPS, this represents a change of -14.3%. Laureate Education currently boasts a Zacks Rank of #1 (Strong Buy). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Adtalem Global Education Inc. (ATGE) : Free Stock Analysis Report Laureate Education (LAUR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
04-04-2025
- Business
- Yahoo
Adtalem (ATGE): Buy, Sell, or Hold Post Q4 Earnings?
Adtalem currently trades at $99.41 and has been a dream stock for shareholders. It's returned 294% since April 2020, nearly tripling the S&P 500's 101% gain. The company has also beaten the index over the past six months as its stock price is up 36% thanks to its solid quarterly results. Is now the time to buy Adtalem, or should you be careful about including it in your portfolio? Get the full stock story straight from our expert analysts, it's free. We're happy investors have made money, but we're swiping left on Adtalem for now. Here are three reasons why ATGE doesn't excite us and a stock we'd rather own. Formerly known as DeVry Education Group, Adtalem Global Education (NYSE:ATGE) is a global provider of workforce solutions and educational services. Examining a company's long-term performance can provide clues about its quality. Any business can have short-term success, but a top-tier one grows for years. Over the last five years, Adtalem grew its sales at a 10.1% compounded annual growth rate. Although this growth is acceptable on an absolute basis, it fell short of our standards for the consumer discretionary sector, which enjoys a number of secular tailwinds. Forecasted revenues by Wall Street analysts signal a company's potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite. Over the next 12 months, sell-side analysts expect Adtalem's revenue to rise by 6.4%, a slight deceleration versus its 8.2% annualized growth for the past two years. This projection is underwhelming and implies its products and services will face some demand challenges. Growth gives us insight into a company's long-term potential, but how capital-efficient was that growth? A company's ROIC explains this by showing how much operating profit it makes compared to the money it has raised (debt and equity). Adtalem historically did a mediocre job investing in profitable growth initiatives. Its five-year average ROIC was 8.8%, somewhat low compared to the best consumer discretionary companies that consistently pump out 25%+. Adtalem isn't a terrible business, but it isn't one of our picks. With its shares beating the market recently, the stock trades at 16.2× forward price-to-earnings (or $99.41 per share). Investors with a higher risk tolerance might like the company, but we think the potential downside is too great. We're pretty confident there are superior stocks to buy right now. Let us point you toward one of our top digital advertising picks. Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio
